We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Single-Cell Analysis Mapping Links Inflammation Response to Acute Myeloid Leukemia

By LabMedica International staff writers
Posted on 24 Jun 2026

Acute inflammation and infection demand rapid production of innate immune cells, a process known as emergency myelopoiesis. More...

When dysregulated, this response can drive chronic inflammation, accelerate aging, and contribute to blood cancers. Understanding how the program is activated and sustained has been a longstanding gap with diagnostic and therapeutic implications. New findings demonstrate a single molecular “switch” that initiates emergency myelopoiesis and links it to acute myeloid leukemia.

Columbia University Irving Medical Center investigators identified a unifying activation mechanism for emergency myelopoiesis and introduced two computational resources, HemaScribe and HemaScape, developed to decode the hematopoietic response at single-cell resolution. The work reveals a common pathway—functioning as an “on” switch—that enables rapid myeloid cell production across diverse physiological insults. The discovery suggests that targeting this shared trigger could help address the overactive state that accelerates aging and fuels malignancy.

The team leveraged single-cell RNA sequencing to capture transcriptional states across tens of thousands of hematopoietic cells and paired these data with new analytics. HemaScribe provides a unified transcript-based classification to standardize cell identities, while HemaScape maps predicted developmental relationships from stem cells to mature lineages. Using these tools, the investigators visualized how emergency activation remodels hematopoiesis and pinpointed the single activation switch.

In translational analyses, cells from many patients with acute myeloid leukemia (AML) displayed a transcriptional signature indicating the emergency program was already engaged, and patients harboring this signature had worse prognosis. The study is published in Cell Stem Cell on June 18. 

The authors note that HemaScribe and HemaScape are freely available to the research community and are already being used to accelerate related projects. With these resources, investigators anticipate applying artificial intelligence to predict drug targets and uncover additional biology embedded in large single-cell datasets. The group also plans to adapt the tools to study blood aging and the restoration of normal immune cell output. 

Related Links
Columbia University Irving Medical Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
AGGRENG-40
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.